Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2 Trial Evaluating the Efficacy and Safety of Cytisinicline in Adults Using Nicotine-containing E-cigarettes

NCT05431387 is registered in ClinicalTrials.gov with Achieve Life Sciences as lead sponsor.

NCT NCT05431387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2 Trial Evaluating the Efficacy and Safety of Cytisinicline in Adults Using Nicotine-containing E-cigarettes
Lead sponsor
Achieve Life Sciences
Phase
Phase 2
Overall status
Completed
Start date
July 13, 2022
Completion date
February 28, 2023
Enrollment
160 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

e-cig use, vaping